Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLOPIDOGREL BISULFATE USP (FORM-1) [ROUTE CODE - "CR1"], with a corresponding US DMF Number 21309.
Remarkably, this DMF maintains an Active status since its submission on February 04, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 01, 2017, and payment made on November 14, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II